Inconsistent clinical outcomes following afatinib treatment in NSCLC patients harboring uncommon epidermal growth factor receptor mutation

BACKGROUND: Uncommon epidermal growth factor receptor (EGFR) mutations consist of a heterogeneous population of molecular alterations, and the available clinical data on the outcomes of patients with non-small-cell lung cancer (NSCLC) harboring uncommon EGFR mutations following afatinib treatment ar...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Wei, Wang, Congjie, Wang, Chunsheng, Zhao, Kewei, Ma, Zhao, Hu, Shanliang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9680984/
https://www.ncbi.nlm.nih.gov/pubmed/36425553
http://dx.doi.org/10.3389/fonc.2022.999606

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9680984/
https://www.ncbi.nlm.nih.gov/pubmed/36425553
http://dx.doi.org/10.3389/fonc.2022.999606

Ejemplares similares